Dermacyd Silver Floral (Lactic Acid) - Photo Evaluation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00932984|
Recruitment Status : Completed
First Posted : July 7, 2009
Last Update Posted : September 14, 2010
To demonstrate the absence of photoirritation and potential photosensitization of the product Dermacyd Silver Floral.
|Condition or disease||Intervention/treatment||Phase|
|Hygiene||Drug: LACTIC ACID(ND)||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||27 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Dermatological Evaluation of the Photo Irritation and Photo Sensitivity Potential for Dermacyd Silver Floral (Lactic Acid).|
|Study Start Date :||June 2009|
|Primary Completion Date :||July 2009|
|Study Completion Date :||July 2009|
Experimental: Dermacyd Silver Floral (Lactic Acid)
Dermacyd Silver Floral (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample.
Drug: LACTIC ACID(ND)
Dermacyd Silver Floral (Lactic Acid) sample will be applied like a curative during 5 weeks (treatment period).
- Measure of the photo irritation test and the photosensitivity by using UVA irradiation and evaluation according International Contact Dermatitis Research Group (ICDRG) scale. Evaluation of the sensibility according to the skin type. [ Time Frame: From the treatment start to the end of the study (treatment period 5 weeks) ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00932984
|Sanofi-Aventis Administrative Office|
|Sao Paulo, Brazil|
|Study Director:||Jaderson Lima||Sanofi|